Procter & Gamble Hygiene & Health Care Ltd. Nine-Monthly Results: Standalone & Consolidated Reports

Nine Monthly Results

Results Snapshot

Figures in Cr

Standalone Nine Monthly Results

Dec'25

Dec'24

Dec'23

Dec'22

Dec'21

Dec'20

Dec'19

Nine Monthly Analysis Highlights

Net Sales

YoY Growth in nine months ended Dec 2025 is 1.13% vs 1.29% in Dec 2024

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 25.26% vs -5.46% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 22.18% vs -8.49% in Dec 2024

Interest

YoY Growth in nine months ended Dec 2025 is -25.41% vs -68.48% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Compare Nine Monthly Results Of P&G Hygiene With

Select Peers

Figures in Cr

Standalone Nine Monthly Results

Change(INR)

Change(%)

Net Sales

3,343.92

4,571.47

-1,227.55

-26.85%

Other Operating Income

5.18

24.88

-19.70

-79.18%

Total Operating income

3,349.10

4,596.35

-1,247.25

-27.14%

Raw Material Cost

567.43

1,421.25

-853.82

-60.08%

Purchase of Finished goods

630.72

1,167.85

-537.13

-45.99%

(Increase) / Decrease In Stocks

10.19

73.86

-63.67

-86.20%

Employee Cost

158.61

325.14

-166.53

-51.22%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

390.18

0.00

390.18

Other Expenses

639.24

595.88

43.36

7.28%

Total Expenditure (Excl Depreciation)

2,396.37

3,583.98

-1,187.61

-33.14%

Operating Profit (PBDIT) excl Other Income

952.73

1,012.37

-59.64

-5.89%

Other Income

30.00

367.60

-337.60

-91.84%

Operating Profit (PBDIT)

982.73

1,379.97

-397.24

-28.79%

Interest

6.34

8.60

-2.26

-26.28%

Exceptional Items

0.00

Gross Profit (PBDT)

976.39

1,371.37

-394.98

-28.80%

Depreciation

27.87

85.18

-57.31

-67.28%

Profit Before Tax

948.52

1,286.19

-337.67

-26.25%

Tax

245.14

263.16

-18.02

-6.85%

Provisions and contingencies

0.00

Profit After Tax

703.38

1,023.03

-319.65

-31.25%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

703.38

1,023.03

-319.65

-31.25%

Equity Capital

32.46

31.20

1.26

4.04%

Face Value

10.00

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

0.00

Operating Profit Margin (Excl OI)

28.45%

22.03%

0.00

6.42%

Gross Profit Margin

29.15%

29.84%

0.00

-0.69%

Public Share Holdings (%)

0.00%

0.00

0.00%

Nine Monthly - Net Sales

Net Sales 3,343.92 Cr

in Dec 2025

Figures in Cr

YoY Growth in nine months ended Dec 2025 is 1.13% vs 1.29% in Dec 2024

Nine Monthly - Standalone Net Profit

Standalone Net Profit 703.38 Cr

in Dec 2025

Figures in Cr

YoY Growth in nine months ended Dec 2025 is 25.26% vs -5.46% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 952.73 Cr

in Dec 2025

Figures in Cr

YoY Growth in nine months ended Dec 2025 is 22.18% vs -8.49% in Dec 2024

Nine Monthly - Interest

Interest 6.34 Cr

in Dec 2025

Figures in Cr

YoY Growth in nine months ended Dec 2025 is -25.41% vs -68.48% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 28.45%

in Dec 2025

Figures in %

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024